Janus Henderson Global Life Sciences Fund Class A (JFNAX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
62.52
+0.93 (1.51%)
May 16, 2025, 8:01 PM EDT
JFNAX Holdings List
As of Feb 28, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | LLY | Eli Lilly and Company | 10.12% |
2 | UNH | UnitedHealth Group Incorporated | 5.99% |
3 | LON: AZN | AstraZeneca PLC | 4.00% |
4 | CPH: NOVO.B | Novo Nordisk A/S | 3.40% |
5 | JNJ | Johnson & Johnson | 3.31% |
6 | ABT | Abbott Laboratories | 3.18% |
7 | BSX | Boston Scientific Corporation | 3.09% |
8 | EPA: SAN | Sanofi | 2.89% |
9 | AMGN | Amgen Inc. | 2.77% |
10 | ABBV | AbbVie Inc. | 2.75% |
11 | VRTX | Vertex Pharmaceuticals Incorporated | 2.68% |
12 | TMO | Thermo Fisher Scientific Inc. | 2.36% |
13 | NVSN.MX | Novartis AG ADR | 2.27% |
14 | ARGX | argenx SE | 2.15% |
15 | ISRG | Intuitive Surgical, Inc. | 2.08% |
16 | SYK | Stryker Corporation | 1.78% |
17 | MRK | Merck & Co., Inc. | 1.75% |
18 | DHR | Danaher Corporation | 1.69% |
19 | AKRO | Akero Therapeutics, Inc. | 1.55% |
20 | ASND | Ascendis Pharma A/S | 1.43% |
21 | SWX: ROG | Roche Holding AG | 1.41% |
22 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.29% |
23 | MCK | McKesson Corporation | 1.22% |
24 | SRPT | Sarepta Therapeutics, Inc. | 1.20% |
25 | PCVX | Vaxcyte, Inc. | 1.15% |
26 | HCA | HCA Healthcare, Inc. | 1.13% |
27 | MDT | Medtronic plc | 1.13% |
28 | GMED | Globus Medical, Inc. | 1.11% |
29 | RVMD | Revolution Medicines, Inc. | 1.07% |
30 | RNA | Avidity Biosciences, Inc. | 1.02% |
31 | COR | Cencora, Inc. | 1.02% |
32 | LNTH | Lantheus Holdings, Inc. | 0.98% |
33 | SLNO | Soleno Therapeutics, Inc. | 0.92% |
34 | DXCM | DexCom, Inc. | 0.88% |
35 | ELV | Elevance Health, Inc. | 0.86% |
36 | PEN | Penumbra, Inc. | 0.81% |
37 | ZTS | Zoetis Inc. | 0.81% |
38 | TEVA | Teva Pharmaceutical Industries Limited | 0.79% |
39 | CVS | CVS Health Corporation | 0.76% |
40 | VRNA | Verona Pharma plc | 0.75% |
41 | HUM | Humana Inc. | 0.73% |
42 | BHVN | Biohaven Ltd. | 0.72% |
43 | MIRM | Mirum Pharmaceuticals, Inc. | 0.69% |
44 | INSP | Inspire Medical Systems, Inc. | 0.61% |
45 | EW | Edwards Lifesciences Corporation | 0.60% |
46 | BBIO | BridgeBio Pharma, Inc. | 0.60% |
47 | ZLAB | Zai Lab Limited | 0.58% |
48 | GILD | Gilead Sciences, Inc. | 0.57% |
49 | COO | The Cooper Companies, Inc. | 0.57% |
50 | ETNB | 89bio, Inc. | 0.56% |
51 | PTCT | PTC Therapeutics, Inc. | 0.55% |
52 | DYN | Dyne Therapeutics, Inc. | 0.49% |
53 | ARDX | Ardelyx, Inc. | 0.45% |
54 | CNC | Centene Corporation | 0.45% |
55 | ALGN | Align Technology, Inc. | 0.44% |
56 | TFX | Teleflex Incorporated | 0.42% |
57 | AVDL | Avadel Pharmaceuticals plc | 0.40% |
58 | TVTX | Travere Therapeutics, Inc. | 0.40% |
59 | STE | STERIS plc | 0.39% |
60 | UTHR | United Therapeutics Corporation | 0.38% |
61 | EWTX | Edgewise Therapeutics, Inc. | 0.36% |
62 | ACLX | Arcellx, Inc. | 0.36% |
63 | JANX | Janux Therapeutics, Inc. | 0.36% |
64 | IDYA | IDEAYA Biosciences, Inc. | 0.34% |
65 | ILMN | Illumina, Inc. | 0.34% |
66 | LEGN | Legend Biotech Corporation | 0.33% |
67 | ALNY | Alnylam Pharmaceuticals, Inc. | 0.32% |
68 | INSM | Insmed Incorporated | 0.31% |
69 | NBIX | Neurocrine Biosciences, Inc. | 0.30% |
70 | SHC | Sotera Health Company | 0.30% |
71 | GPCR | Structure Therapeutics Inc. | 0.28% |
72 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.28% |
73 | ICLR | ICON Public Limited Company | 0.27% |
74 | TYO: 7741 | HOYA Corporation | 0.26% |
75 | XENE | Xenon Pharmaceuticals Inc. | 0.26% |
76 | FOLD | Amicus Therapeutics, Inc. | 0.26% |
77 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.24% |
78 | CYTK | Cytokinetics, Incorporated | 0.23% |
79 | IQV | IQVIA Holdings Inc. | 0.18% |
80 | CGON | CG Oncology, Inc. | 0.16% |
81 | NEO | NeoGenomics, Inc. | 0.16% |
82 | APGE | Apogee Therapeutics, Inc. | 0.16% |
83 | IMNM | Immunome, Inc. | 0.16% |
84 | MTSR | Metsera, Inc. | 0.15% |
85 | PRAX | Praxis Precision Medicines, Inc. | 0.14% |
86 | RCKT | Rocket Pharmaceuticals, Inc. | 0.13% |
87 | n/a | Heartflow Inc - Series F | 0.12% |
88 | n/a | Bicara Therapeutics | 0.12% |
89 | n/a | Curevo Inc | 0.11% |
90 | GERN | Geron Corporation | 0.10% |
91 | FDMT | 4D Molecular Therapeutics, Inc. | 0.08% |
92 | n/a | Attralus Inc Pp | 0.08% |
93 | n/a | Element Biosciences Inc Pp | 0.07% |
94 | n/a | Magnolia Medical Technologies Inc Pp - Series D | 0.06% |
95 | n/a | Asher Biotherapeutics - Series C | 0.06% |
96 | n/a | Shoreline Biosciences Inc Pp | 0.06% |
97 | n/a | Curevo Inc Series B-1 Usd (Private Placement) | 0.05% |
98 | n/a | Beauty Health Co/The | 0.04% |
99 | n/a | Sonoma Biotherapeutics Inc - Series B | 0.04% |
100 | LXEO | Lexeo Therapeutics, Inc. | 0.04% |
101 | EFGBNK.0 03.28.19 0005 | EFG International Finance Guernsey Ltd. | 0.04% |
102 | n/a | Freenome Holdings Inc - Series C | 0.04% |
103 | n/a | Asher Biotherapeutics Inc Pp | 0.03% |
104 | n/a | Twinstrand Biosciences Inc Pp | 0.03% |
105 | n/a | Sonoma Biotherapeutics Inc - Series B-1 | 0.02% |
106 | CRGX | CARGO Therapeutics, Inc. | 0.02% |
107 | n/a | Janus Henderson Cash Liquidity Fund Llc | 0.02% |
108 | BCAX | Bicara Therapeutics Inc. | 0.01% |
109 | n/a | Magnolia Medical Technologies Series E1 Usd | 0.01% |
110 | n/a | Magnolia Medical Technologies C/Wts Usd.001 | 0.00% |
111 | n/a | Clementia Pharmaceuticals Inc | 0.00% |
As of Feb 28, 2025